Mackenzie Financial Corp Bio N Tech Se Transaction History
Mackenzie Financial Corp
- $71.1 Billion
- Q4 2024
A detailed history of Mackenzie Financial Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,903 shares of BNTX stock, worth $447,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,903
Previous 3,903
-0.0%
Holding current value
$447,947
Previous $444,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$943 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$506 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$493 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$218 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$207 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...